BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10489162)

  • 1. Differences in apoptosis induced by anticancer drugs in sublines (SKG-3a, SKG-3b) from a human uterine cervical epidermoid carcinoma.
    Takahashi M; Kataoka S; Kobayashi E; Udagawa Y; Aoki D; Oie S; Kozu A; Nozawa S
    Oncol Res; 1999; 11(2):71-5. PubMed ID: 10489162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological properties of two newly established cell lines (SKG-3a,3b) from a human uterine cervical epidermoid carcinoma].
    Udagawa Y; Nozawa S; Tsukazaki K; Ohta H; Akiba T; Kurihara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):237-46. PubMed ID: 6699456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on hyperthermia and radiation treatment of uterine cancer using multicellular tumor spheroid].
    Tsuchida M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1135-42. PubMed ID: 4031570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer.
    Shimabukuro K; Ichinose S; Koike R; Kubota T; Yamaguchi M; Miyasaka M; Aso T
    Gynecol Oncol; 2001 Nov; 83(2):205-15. PubMed ID: 11606073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells.
    Toyozumi Y; Arima N; Izumaru S; Kato S; Morimatsu M; Nakashima T
    Int J Oncol; 2004 Sep; 25(3):721-8. PubMed ID: 15289875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells.
    Jänicke RU; Engels IH; Dunkern T; Kaina B; Schulze-Osthoff K; Porter AG
    Oncogene; 2001 Aug; 20(36):5043-53. PubMed ID: 11526489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
    Okamura M; Hashimoto K; Shimada J; Sakagami H
    Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose-starved stress in cisplatin-sensitive and -resistant A431 cell line.
    Mese H; Sasaki A; Nakayama S; Yokoyama S; Sawada S; Ishikawa T; Matsumura T
    Anticancer Res; 2001; 21(2A):1029-33. PubMed ID: 11396136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
    Frankel A; Man S; Elliott P; Adams J; Kerbel RS
    Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol.
    Gagnon V; Van Themsche C; Turner S; Leblanc V; Asselin E
    Apoptosis; 2008 Feb; 13(2):259-71. PubMed ID: 18071906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of anticancer drugs on in vitro survival of cell lines derived from various gynecologic tumors (author's transl)].
    Sekiya S; Takamizawa H
    Acta Obstet Gynaecol Jpn; 1981 Mar; 33(3):373-6. PubMed ID: 6163305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth-inhibitory signals by activin A do not affect anticancer drug-sensitivity and acquired multi-drug-resistance in human ovarian endometrioid adenocarcinoma OVK-18 cells.
    Tanaka T; Toujima S; Umesaki N
    Oncol Rep; 2004 Mar; 11(3):667-71. PubMed ID: 14767519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
    Kissel CK; Schadendorf D; Röckmann H
    Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
    Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
    Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation-induced cell death is independent of the apoptotic signals mediated by death-associated protein kinase in human cervical squamous cell carcinoma cells.
    Tanaka T; Bai T; Yukawa K; Umesaki N
    Oncol Rep; 2005 Oct; 14(4):949-55. PubMed ID: 16142356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced radiosensitivity and increased CD40 expression in cyclophosphamide-resistant subclones established from human cervical squamous cell carcinoma cells.
    Tanaka T; Bai T; Yukawa K; Utsunomiya T; Umesaki N
    Oncol Rep; 2005 Oct; 14(4):941-8. PubMed ID: 16142355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.